For the quarter ending 2025-09-30, DRIO made $5,007,000 in revenue. -$18,855,000 in net income. Net profit margin of -376.57%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total revenues | 5,007,000 | 5,369,000 | 6,752,000 | 6,681,000 |
| Service | 613,000 | 821,000 | - | - |
| Hardware And Consumable Products | 1,198,000 | 1,151,000 | - | - |
| Amortization Of Acquired Intangible Assets | 181,000 | 433,000 | - | - |
| Total cost of revenues | 1,992,000 | 2,405,000 | 2,870,000 | 3,364,000 |
| Gross profit | 3,015,000 | 2,964,000 | 3,882,000 | 3,317,000 |
| Research and development | 3,328,000 | 3,721,000 | 4,108,000 | 5,961,500 |
| Sales and marketing | 4,604,000 | 5,231,000 | 5,873,000 | 6,242,500 |
| General and administrative | 4,567,000 | 3,212,000 | 3,310,000 | 5,874,500 |
| Total operating expenses | 12,499,000 | 12,164,000 | 13,291,000 | 18,078,500 |
| Operating loss | -9,484,000 | -9,200,000 | -9,409,000 | -14,761,500 |
| Interest expenses | 1,157,000 | - | - | - |
| Other financial expenses (income), net | 175,000 | - | - | - |
| Total financial expenses (income), net | -982,000 | -3,790,000 | 204,000 | 5,438,500 |
| Loss before taxes | -10,466,000 | -12,990,000 | -9,205,000 | -9,323,000 |
| Income tax (benefit) | - | - | 22,000 | -613,000 |
| Net loss | -10,466,000 | -12,990,000 | -9,227,000 | -8,403,500 |
| Deemed dividend (contribution) | 8,389,000 | 5,572,000 | 4,839,000 | 2,331,500 |
| Net loss attributable to common shareholders | -18,855,000 | -18,562,000 | -14,066,000 | -10,735,000 |
| Earnings per share, basic | 2.96 | 0.18 | 0.14 | 0.14 |
| Earnings per share, diluted | 2.96 | 0.18 | 0.14 | 0.14 |
| Weighted average number of shares outstanding, basic | 3,138,106 | 49,630,949 | 47,370,317 | -15,604,402 |
| Weighted average number of shares outstanding, diluted | 3,138,106 | 49,630,949 | 47,370,317 | -15,604,402 |
DarioHealth Corp. (DRIO)
DarioHealth Corp. (DRIO)